Registered Charity No. 1060134
CME Course

 

From prevention in progression of CKD and related CVD and CKD-MBD problems to kidney transplantation

sarajevo

Sarajevo, National Library

April 5th, 2008

Conference Center, Radon Plaza Hotel 

Sarajevo, Bosnia and Herzegovina

 

ERA-EDTA
European Council for Accreditation in CME in Nephrology, Dialysis and Transplantation
(ECANDT of the ERA-EDTA accredited by the European Accreditation Council for CME - EACCME).

ERA-EDTA European Council for Accreditation in CME in Nephrology, Dialysis and Transplantation (ECANDT of the ERA-EDTA accredited by the European Accreditation Council for CME - EACCME).

Chair-person: R. Coppo (Italy)

Secretary: A.L.M. De Francisco (Spain)

Members: J. Floege (Germany)

              R. Vanholder (Belgium)

              A. Wiecek (Poland)

              C. Zoccali (Italy)

              J. Cannata-Andia, ERA-EDTA President (Spain)

CME Courses Coordinators:
Basic Science and Clinical Nephrology: R. Coppo (Italy) and P. Ronco (France).
Chronic Renal Failure, Hypertension and Clinical Epidemiology: C. Zoccali (Italy) and G. London (France).
Dialysis: R. Vanholder (Belgium), S. Davies (UK) and C. Wanner (Germany).
Transplantation: C. Ponticelli (Italy) and J. Grinyo (Spain).
Collaboration with ISN for courses in Eastern Europe: N. Lameire (Belgium), A. Covic (Romania).

 

 

 

 

 

 

 

 

 

 

 

 

ERA-EDTA Coordinator:
G. Spasovski

 

Local Organiser:

Promo Tours
Ismet Sijercic, Manager
Tel: +387 33 655 346,  715 691
Fax: +387 33 715 690
E-mail: ismet@promotours.ba
Website: www.promotours.ba

 

travelgrants

 

SCIENTIFIC PROGRAMME

 

08.40-09.00 Welcome address: H. Resic, G. Spasovski, N. Lameire, S. Trnačević
   
09.00-09.35 Management of acute kidney injury
  N. Lameire (Belgium)
   
09.35-10.10

Diabetic Nephropathy

  D. Goldsmith (United Kingdom)
   
10.10-10.45 Microalbuminuria, mild renal dysfunction and cardiovascular risk – an update
  A. Covic (Romania)
   
10.45-11.15 Coffee break
   
11.15-11.50 What target of blood Hb concentration is now recommended for CKD patients treated with ESAs?
  A. Wiecek (Poland)
   
11.50-12.25 What is important in the strategy for vascular access for haemodialysis?"
  M. Malovrh (Slovenia)
   
12.25-13.00 Adequate dialysis
  R. Vanholder (Belgium)
   
13.00-14.30 Lunch
   
14.30-15.05 Bone health and vascular calcifications
  G. Spasovski (F.Y.R. of Macedonia)
   
15.05-15.40 Pathogenesis and Management of CKD-MBD. A translational approach
  J. Cannata (Spain)
   
15.40-16.15 Coffee break
   
16.15-16.50 Protocol kidney biopsies - impact on treatment of subclinical rejections
  D. Seron (Spain)
   
16.50-17.10 Acute pancreatitis as a long term complication after kidney transplantation
  E. Mesic (Bosnia and Herzegovina) - Case presentation
   
17.10-17.30 Hemodialysis and malignancy 
  H. Resic (Bosnia and Herzegovina) - Case presentation